PHILADELPHIA, Aug. 25, 2011 /PRNewswire/ — RRY Publications LLC
today announced the preliminary lineup of presenters for the 7th
Annual Stem Cell Summit. The Stem Cell Summit, an intensive one-day
event, that allows attendees to learn about the latest developments
in the stem cell marketplace, evaluate the groundbreaking stem cell
products physicians are using today, and discover the growing
market potential in terms of revenues. For 2012, the Summit will
feature 30+ presenters, a research review & debate session, and
a special track on expanding the range of stem cell therapies.
The 7th Annual Stem Cell Summit will take place on Feb. 21,
2012, at Bridgewaters in the heart of New York City’s historic
South Street Seaport. The preliminary roster of companies and
products featured will include representatives from 2011 presenters
and new 2012 presenters.3DM, Inc.
Histogen Inc.Aastrom Biosciences, Inc.
Incell Corporation, LLCAldagen, Inc.
MaxCyte, Inc.AllCells, LLC
Moraga Biotechnology CorporationAlloSource
NeoStem, Inc.Amedica Corp.
Neuronyx, Inc.Arteriocyte, Inc.
Novocell, Inc.Bio Life Solutions Inc.
NuVasive, Inc.BioE Corp.
Osiris Therapeutics, Inc.BioTime Inc.
Parcell Laboratories LLCCalifornia Stem Cell, Inc.
Pervasis Therapeutics, Inc.Cognate BioServices, Inc.
Progenitor Cell Therapy, Inc.Cord Blood America, Inc.
StemagenCore Dynamics Ltd.
Stemina, Inc.Cytori Therapeutics, Inc.
TiGenix NVGamida Cell Ltd.
Tissue Genesis, Inc.Geron Corp.
Vet-Stem, Inc.Harvest Technologies Corp.In addition to the
company and product overviews, Robin Young, president of RRY
Publications and the organizer of the annual Stem Cell Summit, will
deliver his updated 10-year market forecast for the industry.
7th Annual New York Stem Cell Summit Facts at a
GlanceWhat:Largest Gathering of Stem Cell Company Executives,
Scientists, Investors, and Physi
‘/>”/>
